Different methods of disseminating practice guidelines for children with croup
ISRCTN | ISRCTN73394937 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN73394937 |
ClinicalTrials.gov number | NCT00147849 |
Secondary identifying numbers | MCT-63141 |
- Submission date
- 05/09/2005
- Registration date
- 05/09/2005
- Last edited
- 28/01/2019
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr David Wyatt Johnson
Scientific
Scientific
Alberta Children's Hospital
Room 1562
1820 Richmond Road SW
Calgary
T2T 5C7
Canada
Phone | +1 403 943 7507 |
---|---|
david.johnson@calgaryhealthregion.ca |
Study information
Study design | Cluster controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Scientific title | A cluster controlled trial comparing three methods of disseminating practice guidelines for children with croup |
Study acronym | CPG |
Study objectives | To determine which of the three intervention strategies are most effective at lowering the rate of hospital days per 1000 disease episodes. To determine which of the three dissemination strategies are most effective at increasing the use of therapies of known benefit. |
Ethics approval(s) | University of Calgary Health Research Ethics Board approved on the 7th December 2000 |
Health condition(s) or problem(s) studied | Croup |
Intervention | Group 1: Mailing of printed educational materials (the 'Standard intervention') Group 2: Mailing plus a combination of interactive educational meetings, educational outreach visits, and reminders (a 'Saturn intervention') Group 3: A combination of mailing, interactive sessions, outreach visits, reminders plus identification of local opinion leaders and establishment of local consensus processes (a 'Cadillac intervention') |
Intervention type | Other |
Primary outcome measure | The rate of hospital days per 1000 disease episodes. |
Secondary outcome measures | 1. Proportion of patients treated in the Emergency Department (ED) and hospital with a corticosteroid 2. Proportion of patients evaluated in ED for at least 3 hours after treatment with corticosteroids before the decision to admit to hospital is made 3. Time to treatment with corticosteroids in both ED and hospital patients |
Overall study start date | 01/12/2001 |
Completion date | 31/03/2006 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Child |
Lower age limit | 28 Days |
Upper age limit | 9 Years |
Sex | Both |
Target number of participants | 24 |
Key inclusion criteria | 1. Alberta hospitals were rank ordered based on their rate of hospitalisation and the size of their patient population. The administrative, nursing, and medical staff from the 36 highest ranking hospitals were approached and asked to participate. 24 agreed and 12 refused 2. Children with croup aged 28 days to 9 years, either sex were the subject of the disseminated guidelines |
Key exclusion criteria | Does not meet inclusion criteria |
Date of first enrolment | 01/12/2001 |
Date of final enrolment | 31/03/2006 |
Locations
Countries of recruitment
- Canada
Study participating centre
Alberta Children's Hospital
Calgary
T2T 5C7
Canada
T2T 5C7
Canada
Sponsor information
Alberta Children's Hospital (Canada)
Hospital/treatment centre
Hospital/treatment centre
1820 Richmond Road S.W.
Calgary
T2T 5C7
Canada
Phone | +1 403 229 7211 |
---|---|
david.johnson@calgaryhealthregion.ca | |
Website | http://www.childrenshospital.ab.ca/albertachildrenshospital.html |
https://ror.org/00sx29x36 |
Funders
Funder type
Research organisation
Canadian Institutes of Health Research (CIHR) (Canada) - http://www.cihr-irsc.gc.ca (ref: MCT-63141)
No information available
Alberta Medical Association Medical Services Budget Innovation Fund (Canada)
No information available
Alberta Medical Association Clinical Practice Guideline Program (Canada)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Protocol article | protocol | 28/04/2006 | Yes | No |
Editorial Notes
28/01/2019: Clinicaltrials.gov stated that this trial was terminated by November 2005